| scholarly article | Q13442814 |
| P50 | author | Victoria Metaxa | Q83264756 |
| P2093 | author name string | R Lagoudaki | |
| A Sakadamis | |||
| L Oikonomou | |||
| S Meditskou | |||
| O Thomareis | |||
| P2860 | cites work | Xenon and sevoflurane provide analgesia during labor and fetal brain protection in a perinatal rat model of hypoxia-ischemia | Q21134579 |
| Posthypoxic cooling of neonatal rats provides protection against brain injury | Q24655288 | ||
| Matrix metalloproteinase-9 controls NMDA receptor surface diffusion through integrin beta1 signaling | Q28576606 | ||
| Mild hypothermia decreases the incidence of transient ADC reduction detected with diffusion MRI and expression of c-fos and hsp70 mRNA during acute focal ischemia in rats | Q30622135 | ||
| Laser-Doppler scanning of local cerebral blood flow and reserve capacity and testing of motor and memory functions in a chronic 2-vessel occlusion model in rats | Q31980400 | ||
| Molecular design of the N-methyl-D-aspartate receptor binding site for phencyclidine and dizolcipine. | Q34024207 | ||
| Neuroprotective and neurotoxic properties of the 'inert' gas, xenon | Q34155814 | ||
| Xenon attenuates cerebral damage after ischemia in pigs | Q34413769 | ||
| Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon | Q34453234 | ||
| Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin | Q34464493 | ||
| Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia | Q34479120 | ||
| Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization | Q34486601 | ||
| Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology | Q34724229 | ||
| Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases | Q36734195 | ||
| Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review. | Q37242444 | ||
| Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review | Q37806387 | ||
| Rodent models of cerebral ischemia | Q38735687 | ||
| Extracellular matrix-degrading proteinases in the nervous system | Q40689757 | ||
| Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size | Q42455530 | ||
| Neuroprotective effects of the inhalational anesthetics isoflurane and xenon after cardiac arrest in pigs | Q43070294 | ||
| Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice | Q43610292 | ||
| Effects of xenon on in vitro and in vivo models of neuronal injury | Q44096156 | ||
| Reduction of ischemic brain damage by nitrous oxide and xenon. | Q44606739 | ||
| c-fos mRNA expression in rat cortical neurons during glutamate-mediated excitotoxicity | Q45064304 | ||
| Extracellular correlates of glutamate toxicity in short-term cerebral ischemia and reperfusion: a direct in vivo comparison between white and gray matter | Q46390192 | ||
| Neuroprotection by nitrous oxide: facts and evidence | Q46446570 | ||
| High resolution in situ zymography reveals matrix metalloproteinase activity at glutamatergic synapses. | Q46511701 | ||
| Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. | Q46623106 | ||
| Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study | Q46862725 | ||
| Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia | Q46892046 | ||
| Matrix metalloproteinases inhibition provides neuroprotection against hypoxia-ischemia in the developing brain. | Q46976292 | ||
| Asynchronous administration of xenon and hypothermia significantly reduces brain infarction in the neonatal rat. | Q48315934 | ||
| How does xenon produce anaesthesia? | Q48332940 | ||
| Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia | Q48513991 | ||
| Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats | Q48561229 | ||
| Hippocampal (CA1) activities in Wistar rats from different vendors. Fundamental differences in acute ischemia | Q48580931 | ||
| Expression of c-fos and fos-B proteins following transient forebrain ischemia: effect of hypothermia | Q48839064 | ||
| The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice | Q48950152 | ||
| Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. | Q49133201 | ||
| ANAESTHETIC SOLUBILITY IN BLOOD AND TISSUES: VALUES AND SIGNIFICANCE | Q52764131 | ||
| Xenon Inhibits but N2O Enhances Ketamine-Induced c-Fos Expression in the Rat Posterior Cingulate and Retrosplenial Cortices | Q56068487 | ||
| P433 | issue | 3 | |
| P921 | main subject | xenon | Q1106 |
| P304 | page(s) | 364-369 | |
| P577 | publication date | 2013-12-30 | |
| P1433 | published in | Brain Injury | Q4955769 |
| P1476 | title | Delayed post-ischaemic administration of xenon reduces brain damage in a rat model of global ischaemia | |
| P478 | volume | 28 |
Search more.